Senior insider sale
President, R&D at TAKEDA PHARMACEUTICAL CO LTD — senior position signals high conviction
$363.3K
19.65K shares
What this filing means
PLUMP ANDREW STEWART plans to sell 19.65K shares of TAKEDA PHARMACEUTICAL CO LTD valued at approximately $363.3K. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 8/19/2026ACC: 0001959173-26-006231
DirectorOfficer· President, R&D
Since Mar 2026
19.65K
Shares to sell
$363.3K
Approx. market value
19.65K
Acquired (3 months)
1
Planned
Securities Acquired — Last 3 Months1
RSU's and PSU's
N/A
8/20/2020
19.65KTotal acquired19.65K
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
8/20/2020 | RSU's and PSU's N/A | 19.65K | — |
| Total | 19.65K | ||
Planned & Completed Dispositions1
NYSEPlanned
Units to sell
19.65K
Market value
$363.3K
8/19/2026
Total
Units
19.65K
Value
$363.3K
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
8/19/2026 | 19.65K | $363.3K | NYSE | Planned |
| Total | 19.65K | $363.3K | ||